Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tyroserleutide (YSL), a small molecular tripeptide isolated from porcine spleen degradation products, inhibits the growth and metastasis of human hepatocellular carcinoma (HCC) both in vitro and in vivo.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $133 | In Stock | |
2 mg | $197 | In Stock | |
5 mg | $298 | In Stock | |
10 mg | $453 | In Stock | |
25 mg | $747 | In Stock | |
50 mg | $1,050 | In Stock | |
100 mg | $1,420 | In Stock |
Description | Tyroserleutide (YSL), a small molecular tripeptide isolated from porcine spleen degradation products, inhibits the growth and metastasis of human hepatocellular carcinoma (HCC) both in vitro and in vivo. |
In vitro | Tyroserleutide (YSL) exhibits immunomodulatory properties, notably enhancing concanavalin (ConA) induced proliferation of mouse spleen lymphocytes, augmenting phagocytosis in mouse peritoneal macrophages, and boosting natural killer (NK) cell activity[1]. Additionally, as an immunotherapeutic tripeptide, YSL promotes apoptosis in hepatocarcinoma cells (H22) by downregulating Bcl-2 and cyclin D1 expression[2], establishing it as an effective agent for liver tumor cell apoptosis induction[2]. Moreover, YSL effectively inhibits tumor growth and cell migration without causing significant toxicities in major organs[2]. |
Molecular Weight | 381.42 |
Formula | C18H27N3O6 |
Cas No. | 138168-48-6 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O: Soluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.